Study Participants (n = 7)

Apnea-hypopnea index with Magnap use, mean (SD), events/hour

30.9 (20.4)

Change in apnea-hypopnea index with Magnap use

 Increased, No. (%)

3 (43)

 Decreased, No. (%)

4 (57)

Number of sleep studies per participant

 Pre-pandemic modification, No.

3.2 (1.0)

 Post-pandemic modification, No.

33 (40.0)

Adverse events, No. (%)

0 (0)

Device explanted upon study completion, No. (%)

2 (29)